McBride Dennis bought NRXP
April 9, 2025 · Form 4 insider transaction
McBride Dennis bought 25,000 shares of NRx Pharmaceuticals, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 154 days after the transaction.
Direction
Acquired (buy-side)
Shares
25,000
Price
$0.00
Total value
N/A
InsiderMcBride Dennis
RoleDirector
SecurityStock Option (right to buy)
Transaction codeA: Grant or award
Transaction dateApril 9, 2025
Filing dateSeptember 10, 2025
Shares owned after25,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents stock options ("Options") granted pursuant to the Issuer's 2021 Omnibus Incentive Plan. The Options shall vest on April 9, 2026, subject to continued service to the Issuer.